This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: The Green Cross Corporation. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Yong-Won Shin: Pioneer in Hepatitis B Innovations
Introduction: Yong-Won Shin is an accomplished inventor based in Yongin-si, South Korea, recognized for his significant contributions to the field of medicine, particularly in the development of innovative treatments for hepatitis B. With a total of four patents to his name, Shin has demonstrated a commitment to advancing healthcare through his research and inventions.
Latest Patents: Among Shin's recent patents are two notable inventions concerning the hepatitis B virus. The first patent, titled "Epitope and its use of hepatitis B virus surface antigen," introduces an epitope that remains stable despite potential mutagenesis. This characteristic makes it a promising candidate for developing antibodies and vaccines that can effectively treat hepatitis B without losing efficacy due to viral mutations. The second patent concerns "Human antibodies specifically binding to the hepatitis B virus surface antigen," which outlines the creation of antibodies that can effectively prevent or treat hepatitis B. Both inventions represent significant strides in combating this viral infection.
Career Highlights: Shin currently holds a position at the Green Cross Corporation, a prominent player in the biopharmaceutical industry dedicated to improving global health. His role at the company enables him to apply his expertise and foster innovative solutions for hepatitis B and other medical challenges.
Collaborations: Throughout his career, Yong-Won Shin has collaborated with various talented individuals, including fellow researchers Se-Ho Kim and Ki Young Chang. These partnerships have enhanced his ability to create impactful medical innovations and further advance the field of virology.
Conclusion: Yong-Won Shin's work exemplifies the innovative spirit that drives advancements in medicine. With a focus on hepatitis B, his patents contribute significantly to the ongoing fight against this disease, showcasing the importance of research and collaboration in achieving breakthroughs that can improve health outcomes worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile